Anebulo Pharmaceuticals Stock Forum

$Anebulo Pharmaceuticals(ANEB.US)$ Anebulo Pharmaceuticals Filed U.S. Patent Application #20240010617: Crystalline Forms Of A Cannabinoid Receptor Type 1 (Cb1) Modulator And Methods Of Use And Preparation Thereof

$Anebulo Pharmaceuticals(ANEB.US)$ Anebulo Receives Positive Feedback From FDA On Path To Advance Phase 3 Clinical Development Of ANEB-001 And Completes Dosing Of Phase 2 Extension.

$Anebulo Pharmaceuticals(ANEB.US)$ Target achieved

$Anebulo Pharmaceuticals(ANEB.US)$$8.70 target price
#phase 2
#phase 3 end of 2021